Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 34% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 27% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 1656.29 | 89 / 89 | 100% | 13.19 | 901 / 901 |
prostate | 100% | 1350.05 | 245 / 245 | 100% | 12.52 | 502 / 502 |
skin | 100% | 1245.95 | 1809 / 1809 | 100% | 13.33 | 472 / 472 |
stomach | 100% | 1017.47 | 359 / 359 | 100% | 6.86 | 286 / 286 |
thymus | 100% | 1630.09 | 653 / 653 | 100% | 15.64 | 605 / 605 |
uterus | 100% | 1262.61 | 170 / 170 | 100% | 12.08 | 459 / 459 |
brain | 100% | 1851.44 | 2640 / 2642 | 100% | 19.93 | 705 / 705 |
liver | 100% | 1339.56 | 226 / 226 | 100% | 8.87 | 405 / 406 |
pancreas | 100% | 607.75 | 327 / 328 | 100% | 8.03 | 178 / 178 |
breast | 100% | 1177.22 | 459 / 459 | 100% | 10.65 | 1114 / 1118 |
esophagus | 100% | 960.59 | 1445 / 1445 | 99% | 6.56 | 182 / 183 |
intestine | 100% | 1138.77 | 966 / 966 | 99% | 7.62 | 524 / 527 |
ovary | 100% | 978.21 | 180 / 180 | 99% | 7.31 | 427 / 430 |
bladder | 100% | 940.33 | 21 / 21 | 99% | 8.57 | 500 / 504 |
adrenal gland | 100% | 1485.70 | 258 / 258 | 99% | 13.64 | 228 / 230 |
lung | 99% | 832.37 | 574 / 578 | 100% | 9.52 | 1152 / 1155 |
eye | 0% | 0 | 0 / 0 | 100% | 16.44 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.55 | 29 / 29 |
muscle | 100% | 1625.14 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1107.68 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.66 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.27 | 1 / 1 |
adipose | 100% | 1008.99 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 100% | 1950.85 | 858 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 584.35 | 1315 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 69% | 496.18 | 642 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051123 | Biological process | RNA polymerase II preinitiation complex assembly |
GO_0060261 | Biological process | positive regulation of transcription initiation by RNA polymerase II |
GO_0032968 | Biological process | positive regulation of transcription elongation by RNA polymerase II |
GO_0016592 | Cellular component | mediator complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0070847 | Cellular component | core mediator complex |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003712 | Molecular function | transcription coregulator activity |
Gene name | MED9 |
Protein name | Mediator of RNA polymerase II transcription subunit 9 (Mediator complex subunit 9) Mediator complex subunit 9 |
Synonyms | MED25 |
Description | FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. |
Accessions | J3KTK5 Q9NWA0 ENST00000580462.1 ENST00000581315.1 ENST00000268711.4 |